Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation in Sickle Cell Disease
NCT06260891Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Feb 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zinc in sickle cell disease (SCD), sponsored by University of California, San Francisco. Started Feb 2026; status: recruiting.
02
Drugs
zinc
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT06260891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06260891.